| Literature DB >> 35399893 |
José Renan Miranda Cavalcante Filho1, Patrícia Rodrigues Naufal Spir2, Gustavo Maldonado Cortez3, Adib Saraty Malveira1, Felipe Franco Pinheiro Gaia4.
Abstract
Background: Histoplasmosis is a fungal disease endemic in some regions of the United States of America, Canada, and Latin America. The geographic characteristics, humidity, soil, and climate are responsible for such distribution. In Brazil, there are case reports of histoplasmosis throughout its territory, being considered an endemic region. It is considered an opportunistic disease, affecting mostly immunocompromised patients. To the present date, scientific publications dealing with pediatric cases of histoplasmosis are restricted to case series. Spinal cord injuries caused by histoplasmosis are rare, even in the adult population, being described in few studies. Case Description: The present report deals with a 4-year-old patient, from the southeast region of Brazil, who started a condition of fever, weight loss, cervicobrachialgia, and symmetrical tetraparesis, with evolution over 2 months. In the diagnostic investigation, she was found to have primary immunodeficiency and neuroimaging examinations showed a cervical spinal cord lesion at the level of C4-C6. The anatomopathological diagnosis of histoplasmosis was possible after surgery for decompression and biopsy of the lesion.Entities:
Keywords: Histoplasmosis; Neuroinfection; Neurosurgery; Pediatrics; Spinal cord lesion
Year: 2022 PMID: 35399893 PMCID: PMC8986645 DOI: 10.25259/SNI_1064_2021
Source DB: PubMed Journal: Surg Neurol Int ISSN: 2152-7806
Figure 1:(a) Pretreatment T1-weighted magnetic resonance imaging (MRI) of cervical spine, sagittal view, showing multiple contrast-enhancing solid intramedullary expansive formations. The intramedullary lesion between C4 and C6 stands out, with dimensions: 14 mm in diameter caudal, 7 mm anteroposterior, and 8.2 mm laterolateral, as well as leptomeningeal enhancement. (b) T2-weighted posttreatment MRI with significant reduction in meningeal enhancement, denoting the resolution of the infectious process after the implemented therapy; (c) pretreatment T1-weighted axial MRI of the brain showing the important diffuse leptomeningeal enhancement in the basal region of the brain, typical of granulomatous diseases. (d) MRI after 42 days of T1-weighted treatment showing the important reduction in meningeal enhancement.
Figure 2:Photomicroscopy of spinal cord lesion (a) – Detail of the inflammatory process, where epithelioid macrophages, lymphocytes, and a multinucleated giant cell are observed (hematoxylin-eosin, ×400). (b) Detail of fungal structures, which do not present budding (Gomori-Grocott, ×100).
Blood tests